Vitamin D receptor signaling enhances locomotive ability in mice

Journal of Bone and Mineral Research

Volumn 30, Issue 1, 2015, Pages 128-136

  Sakai, Sadaoki ^a   Suzuki, Miho ^a   Tashiro, Yoshihito ^a   Tanaka, Keisuke ^a   Takeda, Satoshi ^a   Aizawa, Ken ^a   Hirata, Michinori ^a   Yogo, Kenji ^a   Endo, Koichi ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Preclinical studies; Sarcopenia

Indexed keywords

CELL NUCLEUS RECEPTOR; COLECALCIFEROL; ELDECALCITOL; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; INSULIN-LIKE GROWTH FACTOR-1, MOUSE; SOMATOMEDIN C; VITAMIN; VITAMIN D;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXERCISE; EXTENSOR DIGITORUM LONGUS MUSCLE; FRACTURE; GENE EXPRESSION; LOCOMOTION; MOUSE; NERVOUS TISSUE; NEUROMUSCULAR SYNAPSE; NONHUMAN; PERIPHERAL NERVE; QUALITY OF LIFE; SCHWANN CELL; SCIATIC NERVE; SIGNAL TRANSDUCTION; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; RAT; SKELETAL MUSCLE;

ANIMALS; CHOLECALCIFEROL; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; MUSCLE, SKELETAL; PHYSICAL CONDITIONING, ANIMAL; RATS; RECEPTORS, CALCITRIOL; SCHWANN CELLS; SIGNAL TRANSDUCTION; VITAMIN D; VITAMINS;

EID: 84919884458     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2317     Document Type: Article

References (35)

1. WHO. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group. World Health Organ Tech Rep Ser. 1994;843:1-129
2. Ensrud KE, Thompson DE, Cauley JA, et al. Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc. 2000;48(3):241.9
3. Nguyen ND, Center JR, Eisman JA, Nguyen TV. Bone loss, weight loss, and weight fluctuation predict mortality risk in elderly men and women. J Bone Miner Res. 2007;22(8):1147.54
4. Gardsell P, Johnell O, Nilsson BE, Nilsson JA. The predictive value of fracture, disease, and falling tendency for fragility fractures in women. Calcif Tissue Int. 1989;45(6):327-30
5. Uchiyama Y, Higuchi Y, Takeda S, et al. ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis. Bone. 2002;30(4): 582.8
6. Matsumoto T, Ito M, Hayashi Y, et al. A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures.a randomized, active comparator, double-blind study. Bone. 2011;49(4): 605.12
7. Dennison E, Cooper C. Epidemiology of osteoporotic fractures. Horm Res. 2000;54(Suppl 1):58.63
8. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: A meta-Analysis of randomized controlled trials. JAMA. 2005;293(18):2257.64
9. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental,active forms of vitamin D: A metaanalysis of randomised controlled trials. BMJ. 2009;339:b3692
10. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: A meta-Analysis. JAMA. 2004;291(16):1999.2006
11. Faulkner KA, Cauley JA, Zmuda JM, et al. Higher 1,25-dihydroxyvitamin D3 concentrations associated with lower fall rates in older community-dwelling women. Osteoporos Int. 2006;17(9):1318.28
12. Yoshizawa T, Handa Y, Uematsu Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet. 1997;16(4):391.6
13. Zhu TS, Glaser M. Neuroprotection and enhancement of remyelination by estradiol and dexamethasone in cocultures of rat DRG neurons and Schwann cells. Brain Res. 2008;1206:20.32
14. Doherty TJ, Vandervoort AA, Taylor AW, Brown WF. Effects of motor unit losses on strength in older men and women. J Appl Physiol. 1993;74(2):868-74
15. Takasu H, Sugita A, Uchiyama Y, et al. c-Fos protein as a target of antiosteoclastogenic action of vitamin D, and synthesis of new analogs. J Clin Invest. 2006;116(2):528-35
16. Sakai S, Takaishi H, Matsuzaki K, et al. 1-Alpha, 25-dihydroxy vitamin D3 inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression. J Bone Miner Metab. 2009;27(6):643.52
17. Harada S, Mizoguchi T, Kobayashi Y, et al. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone. J Bone Miner Res. 2012;27(2):461-73
18. Kikuta J, Kawamura S, Okiji F, et al. Sphingosine-1-phosphatemediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D. Proc Natl Acad Sci USA. 2013;110(17):7009.13
19. Nakamura K. A "super-Aged" society and the "locomotive syndrome." J Orthop Sci. 2008;13(1):1-2
20. Nakamura K. The concept and treatment of locomotive syndrome: Its acceptance and spread in Japan. J Orthop Sci. 2011;16(5):489-91
21. Garcia LA, King KK, Ferrini MG, Norris KC, Artaza JN. 1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology. 2011; 152(8):2976.86
22. Endo I, Inoue D, Mitsui T, et al. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology. 2003;144(12):5138.44
23. Andersen NB, Andreassen TT, Orskov H, Oxlund H. Growth hormone and mild exercise in combination increases markedly muscle mass and tetanic tension in old rats. Eur J Endocrinol. 2000;143(3):409.18
24. Carlberg C, Dunlop TW. The impact of chromatin organization of vitamin D target genes. Anticancer Res. 2006;26(4A):2637-45
25. Clark BC, Taylor JL. Age-related changes in motor cortical properties and voluntary activation of skeletal muscle. Curr Aging Sci. 2011;4(3):192.9
26. Payne AM, Zheng Z, Messi ML, Milligan CE, González E, Delbono O. Motor neurone targeting of IGF-1 prevents specific force decline in ageing mouse muscle. J Physiol. 2006;570(Pt 2):283-94
27. Apel PJ, Alton T, Northam C, et al. How age impairs the response of the neuromuscular junction to nerve transection and repair: An experimental study in rats. J Orthop Res. 2009;27(3):385-93
28. Pellitteri R, Russo A, Stanzani S. Schwann cell: A source of neurotrophic activity on cortical glutamatergic neurons in culture. Brain Res. 2006;1069(1):139-44
29. Melcangi RC, Magnaghi V, Cavarretta I, Martini L, Piva F. Age-induced decrease of glycoprotein Po and myelin basic protein gene expression in the rat sciatic nerve. Repair by steroid derivatives. Neuroscience. 1998;85(2):569-78
30. Peterson AC, Bray GM. Hypomyelination in the peripheral nervous system of shiverer mice and in shiverer in equilibrium normal chimaera. J Comp Neurol. 1984;227(3):348-56
31. Gao WQ, Shinsky N, Ingle G, Beck K, Elias KA, Powell-Braxton L. IGF-I deficient mice show reduced peripheral nerve conduction velocities and decreased axonal diameters and respond to exogenous IGF-I treatment. J Neurobiol. 1999;39(1):142-52
32. Cheng HL, Randolph A, Yee D, Delafontaine P, Tennekoon G, Feldman EL. Characterization of insulin-like growth factor-I and its receptor and binding proteins in transected nerves and cultured Schwann cells. J Neurochem. 1996;66(2):525-36
33. Apel PJ, Ma J, Callahan M, et al. Effect of locally delivered IGF-1 on nerve regeneration during aging: An experimental study in rats. Muscle Nerve. 2010;41(3):335-41
34. Rojas Vega S, Knicker A, Hollmann W, Bloch W, Strüder HK. Effect of resistance exercise on serum levels of growth factors in humans. Horm Metab Res. 2010;42(13):982-6
35. Toogood AA, Shalet SM. Ageing and growth hormone status. Baillieres Clin Endocrinol Metab. 1998;12(2):281-96.